Day One Biopharmaceuticals Inc (DAWN)
16.18
+0.14
(+0.90%)
USD |
NASDAQ |
May 17, 16:00
16.18
0.00 (0.00%)
After-Hours: 20:00
Day One Biopharmaceuticals Enterprise Value: 1.083B for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 1.083B |
| May 15, 2024 | 1.117B |
| May 14, 2024 | 1.134B |
| May 13, 2024 | 1.085B |
| May 10, 2024 | 1.080B |
| May 09, 2024 | 1.114B |
| May 08, 2024 | 1.116B |
| May 07, 2024 | 1.175B |
| May 06, 2024 | 1.133B |
| May 03, 2024 | 1.183B |
| May 02, 2024 | 1.217B |
| May 01, 2024 | 1.228B |
| April 30, 2024 | 1.176B |
| April 29, 2024 | 1.122B |
| April 26, 2024 | 985.72M |
| April 25, 2024 | 836.31M |
| April 24, 2024 | 1.009B |
| April 23, 2024 | 1.136B |
| April 22, 2024 | 1.026B |
| April 19, 2024 | 989.22M |
| April 18, 2024 | 1.058B |
| April 17, 2024 | 979.61M |
| April 16, 2024 | 958.64M |
| April 15, 2024 | 892.23M |
| April 12, 2024 | 885.24M |
| Date | Value |
|---|---|
| April 11, 2024 | 910.58M |
| April 10, 2024 | 941.16M |
| April 09, 2024 | 938.54M |
| April 08, 2024 | 901.84M |
| April 05, 2024 | 955.14M |
| April 04, 2024 | 922.81M |
| April 03, 2024 | 1.045B |
| April 02, 2024 | 1.066B |
| April 01, 2024 | 1.094B |
| March 28, 2024 | 1.077B |
| March 27, 2024 | 1.013B |
| March 26, 2024 | 989.75M |
| March 25, 2024 | 946.06M |
| March 22, 2024 | 992.37M |
| March 21, 2024 | 949.55M |
| March 20, 2024 | 915.48M |
| March 19, 2024 | 839.46M |
| March 18, 2024 | 850.82M |
| March 15, 2024 | 891.01M |
| March 14, 2024 | 873.64M |
| March 13, 2024 | 934.81M |
| March 12, 2024 | 920.83M |
| March 11, 2024 | 957.53M |
| March 08, 2024 | 993.36M |
| March 07, 2024 | 989.87M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
91.41M
Minimum
May 27 2022
1.557B
Maximum
Aug 12 2022
877.45M
Average
910.56M
Median
Enterprise Value Benchmarks
| Revolution Medicines Inc | 4.729B |
| Zentalis Pharmaceuticals Inc | 360.33M |
| Perspective Therapeutics Inc | 890.47M |
| Electromed Inc | 135.95M |
| Xtant Medical Holdings Inc | 106.24M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -62.41M |
| Total Expenses (Quarterly) | 66.77M |
| EPS Diluted (Quarterly) | -0.72 |
| Earnings Yield | -15.52% |
| Operating Earnings Yield | 19.00% |
| Normalized Earnings Yield | 13.10 |